Septin 9 Methylation Analysis Bisulfite Conversion

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Current methods for methylation analysis, particularly for the septin 9 gene, are not suitable for use in reference laboratories and face challenges such as low DNA yields from remote samples, DNA degradation, and the need for high sensitivity and specificity in detecting methylation patterns.

Innovation Solution

A method involving the treatment of genomic DNA with reagents to convert unmethylated cytosine to uracil sulfonate while leaving methylated cytosine unchanged, followed by amplification using specific oligonucleotides and subsequent analysis to detect methylation of CpG dinucleotides, utilizing bisulfite conversion and heat-stable polymerase for enhanced sensitivity and specificity.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Reliability

If conventional methylation analysis methods are used, then the analysis can be performed, but the sensitivity and reliability are insufficient for reference laboratory use

Engineering Contradiction:
ImprovereliabilityVSAvoidsensitivity
Core Design Contradiction:
ReliabilityVSMeasurement precision

Solution Approach 1:

The method segments the methylation analysis into distinct stages: bisulfite conversion of unmethylated cytosines, selective amplification using methylation-specific primers, and detection. This segmentation allows each step to be optimized independently, improving overall reliability and sensitivity for reference laboratory use.

Inventive Principle:
Principle #1Segmentation

Solution Approach 2:

The patent introduces bisulfite conversion as an intermediary step that chemically modifies unmethylated cytosines to uracil while leaving methylated cytosines unchanged. This intermediary transformation creates detectable differences between methylated and unmethylated DNA sequences, enabling highly sensitive and reliable methylation detection.

Inventive Principle:
Principle #24Intermediary (Mediator)

2Ease of operation

If remote samples are used to reduce invasiveness, then patient comfort improves, but DNA yield is low and DNA degradation occurs

Engineering Contradiction:
Improveease of samplingVSAvoidDNA yield
Core Design Contradiction:
Ease of operationVSQuantity of substance

Solution Approach 1:

The method performs preliminary optimization of the bisulfite conversion and amplification conditions specifically designed for low-input DNA from remote samples. By pre-optimizing these parameters, the method maximizes DNA utilization and minimizes degradation, enabling reliable analysis even from limited remote sample quantities.

Inventive Principle:
Principle #10Preliminary action

Solution Approach 2:

The patent modifies key reaction parameters including bisulfite treatment time, temperature, and polymerase chain reaction conditions to be optimized for low DNA input. These parameter changes ensure high efficiency DNA conversion and amplification from remote samples while minimizing degradation.

Inventive Principle:
Principle #35Parameter changes

3Measurement precision

If high sensitivity detection is implemented, then diagnostic accuracy improves, but false positives increase

Engineering Contradiction:
ImprovesensitivityVSAvoidspecificity
Core Design Contradiction:
Measurement precisionVSReliability

Solution Approach 1:

The method employs primers with locally optimized sequences that target specific methylation patterns in the septin 9 gene promoter region. By designing primers with high local specificity to methylated CpG sites, the method achieves high sensitivity while minimizing cross-reactivity and false positives through precise local sequence matching.

Inventive Principle:
Principle #3Local quality

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

This method provides a highly sensitive and reliable detection of septin 9 gene methylation, doubling sensitivity and maintaining DNA integrity, making it suitable for reference laboratory use and improving diagnostic accuracy for cellular proliferative disorders like colon and liver carcinomas.

Implementation Method 1

treating genomic DNA with one or more reagents to convert unmethylated cytosine bases to uracil sulfonate or to another base having a different binding behavior than cytosine, while methylated cytosine remains unchanged

Methodology Applied
Scientific EffectBisulfite conversion: Chemical Bonding

Implementation Method 2

amplifying the treated DNA by means of specific oligonucleotides and subsequent analysis to detect methylation of CpG dinucleotides, utilizing bisulfite conversion and heat-stable polymerase for enhanced sensitivity and specificity

Methodology Applied
Scientific EffectDNA amplification: Enzyme

Data Source

PatentEP2479289B1Method for methylation analysis
Publication Date: 2016.04.06 EPIGENOMICS AG
  • EP2479289B1 patent drawingFigure 1
  • EP2479289B1 patent drawingFigure 2
  • EP2479289B1 patent drawingFigure 3

AI summary

Aspects of the invention relate to composition and methods for the providing of DNA for methylation analysis that is in particular suitable to be applied in reference laboratories. Further aspects of the invention relate to composition and methods for the highly specific and sensitive methylation analysis of the Septin 9 gene also in particular suitable to be applied in reference laboratories.